Stephen Ting

12PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 19, 2026
A randomized phase 2 study combining midostaurin, low-dose cytarabine and venetoclax in newly diagnosed AML ≥60 years.

|Aug 03, 2026
Role of FibroScan in evaluating hepatic involvement in systemic amyloidosis: a single-centre prospective pilot study.

|Mar 02, 2026
Thrombopoietin Receptor Agonists Plus Immunosuppressive Therapy in Aplastic Anaemia: A Systematic Review and Meta-Analysis.

Elham Ashrafi, Lauren Young, Lucy C Fox

|Feb 22, 2026
An Australian Amyloidosis Network analysis of Australian patients with immunoglobulin light chain amyloidosis treated with bortezomib-based chemotherapy.

Anthea Gibbons, Lipi Chakravorty, Hasib Sidiqi

|Nov 21, 2025
Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy.

Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos

|Jan 18, 2025
Final analysis of the phase 1b Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT).

Chong Chyn Chua, Sun Loo, Chun Yew Fong

Pageof 2

Frequent Collaborators

7 joint publications

Andrew H Wei

5 joint publications

Ing Soo Tiong

4 joint publications

Pau Montesinos

3 joint publications

John Reynolds